Alkem Laboratories and Tata Memorial Centre (TMC) have joined to set up an advanced radiotherapy facility in Muzaffarpur, Bihar as a part of the Homi Bhabha Cancer Hospital and Research Center (HBCHRC). As part of its CSR activity, Alkem Laboratories has approved the purchase of two advanced versions of the teletherapy and brachytherapy units for […]
Day One Biopharmaceuticals has signed a licensing agreement with Merck to develop and commercialize pimasertib and MSC2015103B, two oral, small molecule allosteric inhibitors of MEK 1/2. MEK 1/2 is a key enzyme in the MAPK signaling pathway whose dysregulation has been shown to occur in various cancers. Pimasertib has been evaluated in over 10 phase […]
OncoSec Medical has dosed the first patient in the OMS-104 phase 2 clinical trial, which is evaluating TAVO (tavokinogene telseplasmid) in combination with OPDIVO (nivolumab) as a neoadjuvant therapy for melanoma. TAVO is OncoSec Medical’s intratumoral DNA plasmid-based interleukin-12 (IL-12) therapy, which is intended to be administered using its gene delivery platform (gene electrotransfer). On […]
Olympus Corporation has signed a deal worth up to $340 million to acquire Veran Medical Technologies (VMT), a Missouri-based provider of advanced medical devices specializing in interventional pulmonology. The Japanese optical products company will carry out the acquisition via its subsidiary Olympus Corporation of the Americas (OCA). It is said to be the latest in […]
US pharma giant Pfizer has entered into a collaboration deal worth up to $480 million with Chinese biopharma company CStone Pharmaceuticals to address the oncological needs in China. CStone Pharmaceuticals is engaged in developing and commercializing immuno-oncology and precision medicines for cancer patients. The collaboration will be formed between the Chinese firm and Pfizer’s subsidiaries […]
Galecto, a Danish biotech company, has raised $64 million in an equity financing round, for developing novel treatments for fibrosis and cancer. Led by Soleus Capital and co-led by Eir Ventures, the funding round is said to strengthen the existing cash balance of Galecto, extending its cash runway into late 2022. The financing round saw […]
Illumina acquisition of GRAIL : US sequencing company Illumina has agreed to fully acquire California-based cancer screening company GRAIL in a cash and stock deal worth $8 billion. It was Illumina which had established GRAIL in 2016. Subsequently, it was separated as an independent company driven by Illumina’s NGS technology for developing data science and […]
Galera Therapeutics said that it has wrapped up enrollment of patients for its phase 1b/2a safety and anti-cancer efficacy clinical trial of the combination of avasopasem manganese (GC4419) with stereotactic body radiation therapy (SBRT) in patients having locally advanced pancreatic cancer (LAPC). The US biotech company said that its investigational, selective small molecule superoxide dismutase (SOD) […]
ABM Therapeutics said that the first cancer patient has been enrolled and dosed with its lead candidate ABM-1310, a BRAF inhibitor, in a phase 1 clinical trial in the US. According to the clinical-stage biopharma company, the BRAF inhibitor had shown superior properties in pre-clinical animal models. The brain-penetrant small molecule is expected to be […]
Ascentage Pharma has entered into a clinical collaboration with Acerta Pharma, the hematology research and development center of excellence of AstraZeneca to assess the combination of Bcl-2 and Bruton’s Tyrosine Kinase (BTK) inhibitors in a type of lymphoma. As per the collaboration terms, Ascentage Pharma will sponsor a clinical trial to evaluate the efficacy and […]